Cargando…

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction

Worldwide, colorectal cancer (CRC) is a deadly disease whose death rate ranks second among cancers though its incidence ranks third. Early CRC detection is key and is associated with improved survival outcomes. However, existing tests for CRC diagnosis have several weaknesses thus rendering them ine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassar, Farah J., Msheik, Zahraa S., Nasr, Rihab R., Temraz, Sally N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130320/ https://www.ncbi.nlm.nih.gov/pubmed/34001239 http://dx.doi.org/10.1186/s13148-021-01095-5

Ejemplares similares

Circulating miRNA as Biomarkers for Colorectal Cancer Diagnosis and Liver Metastasis
por: Nassar, Farah J., et al.
Publicado: (2021)

Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
por: Temraz, Sally, et al.
Publicado: (2019)

Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer
por: Baassiri, Amro, et al.
Publicado: (2020)

Inflammatory Markers and MicroRNAs: The Backstage Actors Influencing Prognosis in Colorectal Cancer Patients
por: Nasr, Rihab, et al.
Publicado: (2018)

miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer
por: Msheik, Zahraa S., et al.
Publicado: (2022)

The Crosstalk between Microbiome and Immune Response in Gastric Cancer
por: Nasr, Rihab, et al.
Publicado: (2020)

Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome
por: Temraz, Sally, et al.
Publicado: (2021)

Can plasma vitamin C predict survival in stage IV colorectal cancer patients? Results of a prospective cohort study
por: Temraz, Sally, et al.
Publicado: (2023)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications
por: El Halabi, Ibrahim, et al.
Publicado: (2018)

Insights on the Biomarker Potential of Exosomal Non-Coding RNAs in Colorectal Cancer: An In Silico Characterization of Related Exosomal lncRNA/circRNA–miRNA–Target Axis
por: Mezher, Maria, et al.
Publicado: (2023)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Circulating Biomarkers of Colorectal Cancer (CRC)—Their Utility in Diagnosis and Prognosis
por: Łukaszewicz-Zając, Marta, et al.
Publicado: (2021)

Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020)

Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
por: Lin, Wu-Hao, et al.
Publicado: (2021)

NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer
por: Raunkilde, Louise, et al.
Publicado: (2022)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Methylated circulating tumor DNA in blood: power in cancer prognosis and response
por: Warton, Kristina, et al.
Publicado: (2016)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis
por: Cheuk, Isabella Wai Yin, et al.
Publicado: (2017)

Applying circulating tumor DNA methylation in the diagnosis of lung cancer
por: Li, Lei, et al.
Publicado: (2019)

Predicting disease-free survival in colorectal cancer by circulating tumor DNA methylation markers
por: Yang, Xin, et al.
Publicado: (2022)

A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer
por: Itani, Maha M., et al.
Publicado: (2021)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Novel Methylation Biomarkers for Colorectal Cancer Prognosis
por: Gutierrez, Alvaro, et al.
Publicado: (2021)

Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
por: Hao, T B, et al.
Publicado: (2014)

Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection
por: Nassar, Farah J., et al.
Publicado: (2020)

Tumor DNA Methylation Profiles Enable Diagnosis, Prognosis Prediction, and Screening for Cervical Cancer
por: Tu, Jiannan, et al.
Publicado: (2022)

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study
por: Mo, Shaobo, et al.
Publicado: (2022)

Giant Inflatable Colon Model Enhances Lebanese Community Knowledge and Intention for Colorectal Cancer Screening
por: Baassiri, Amro, et al.
Publicado: (2020)

Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection
por: Fang, Qingxiao, et al.
Publicado: (2023)

Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer
por: Osumi, Hiroki, et al.
Publicado: (2020)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
por: Thomsen, Caroline B., et al.
Publicado: (2020)

Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors
por: Draškovič, Tina, et al.
Publicado: (2023)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
por: He, Yiping, et al.
Publicado: (2020)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

DNA methylation as an epigenetic biomarker in colorectal cancer
por: SILVA, TIAGO DONIZETTI, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ui1r14lonh667mrmfed5p7rr55